How to appeal an Elevance Health immune globulin (ivig/scig) for pidd denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.

What Elevance Health's policy requires for immune globulin (ivig/scig) for pidd

Cited policy: BCBS Federal Employee Program / BCBSA Medical Policy on Immune Globulin Therapy

Route conversion (IVIG → SCIG / fSCIG) requires documented clinical indication: IVIG adverse reaction, venous access difficulty, patient preference with stable disease, or steady-state trough optimization. Continued PIDD diagnosis criteria.

How Elevance Health denies immune globulin (ivig/scig) for pidd — and how to counter it

Where Elevance Health pushes back: 1) Patient stable on IVIG — no reason to change; 2) Brand-specific (Privigen vs Gamunex) swap not justified.

Counter-arguments that hold up: Cite specific IVIG reaction (headache / aseptic meningitis / hemolysis / TE / IgA-anti-IgA anaphylaxis) with date, premed-failure documentation. Berger 2008 SCIG meta — fewer systemic AEs. Orange 2010 trough-pneumonia data — SCIG steadier troughs reduce breakthrough infections. Mahlaoui QoL — improved treatment-satisfaction. Excipient differences (proline / glycine / sorbitol / maltose) matter — Bonilla 2015 SS supports product-specific selection when reactions documented. Line-related complications (DVT, CLABSI) justify route change.

What Elevance Health typically denies for immune globulin (ivig/scig) for pidd

Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For immune globulin (ivig/scig) for pidd, expect:

• Step therapy
• Medical necessity for biologics
• Out-of-network for behavioral health
• Bariatric surgery prior auth

Treatments most often denied in this category

These are the immune globulin (ivig/scig) for pidd treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Privigen (IVIG)
• Gamunex-C (IVIG)
• Octagam (IVIG)
• Gammagard Liquid (IVIG)
• Flebogamma DIF (IVIG)
• Bivigam (IVIG)

How to submit the appeal to Elevance Health

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
3. File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.